Human IL-2Rɑ subunit binding modulation of IL-2 through a decline

Europe PMC is an archive of life sciences journal literature.

Modification of IL-2 for anticancer therapy. (A) Mutations in CD122

Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles

Ligand-induced type II interleukin-4 receptor dimers are sustained by rapid re-association within plasma membrane microcompartments

SDS-PAGE and Western blotting analysis of the recombinant proteins.

Arezoo BP, Pasteur Institute of Iran, Tehran

Comparison of the effects of probiotic strains (Lactobacillus

A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic, AMB Express

IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression

Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach